CARBELYTE ELECTROLYTE & VITAMIN B REPLACER FOR HORSES Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

carbelyte electrolyte & vitamin b replacer for horses

carbine chemicals pty ltd - bicarbonate ions | carbonate | nicotinic acid | calcium | chloride | potassium | magnesium | sodium | sulfate | choline bitartrate | inositol | vitamin b12 = cyanocobalamin | vitamin b2 = riboflavin | vitamin b1 = thiamine | vitamin b6 = pyridoxine | vitamin e | vitamin m = folic acid = pga - nutrition & metabolism - horse | colt | donkey | endurance horse | filly | foal | gelding | high performance horses | horses at stud | mare | pacer | pol - not applicable (vet)

SODIUM BICARBONATE 500 MG Israel - English - Ministry of Health

sodium bicarbonate 500 mg

rekah pharmaceutical industry ltd, israel - sodium bicarbonate - tablets - sodium bicarbonate 500 mg - sodium bicarbonate - sodium bicarbonate - antacid.

Phebra SODIUM BICARBONATE 8.4% w/v 840 mg/10 mL injection BP vial Australia - English - Department of Health (Therapeutic Goods Administration)

phebra sodium bicarbonate 8.4% w/v 840 mg/10 ml injection bp vial

phebra pty ltd - sodium bicarbonate, quantity: 84 mg/ml - injection, solution - excipient ingredients: disodium edetate; water for injections - sodium bicarbonate injection is indicated as an alkalinising agent in the treatment of metabolic acidosis which may occur in many conditions including diabetes, starvation, hepatitis, cardiac arrest, shock, severe dehydration, renal insufficiency, severe diarrhoea, addison's disease or administration of acidifying salts (e.g. excessive sodium chloride, calcium chloride, ammonium chloride). sodium bicarbonate injection is also used to increase urinary ph in order to increase the solubility of certain weak acids (e.g. cystine, sulphonamides, uric acid) and in the treatment of certain intoxications (e.g. methanol, phenobarbitone, salicylates, lithium) to decrease renal absorption of the drug or to correct acidosis.

Phebra SODIUM BICARBONATE 8.4% w/v 8.4 g/100 mL injection BP vial Australia - English - Department of Health (Therapeutic Goods Administration)

phebra sodium bicarbonate 8.4% w/v 8.4 g/100 ml injection bp vial

phebra pty ltd - sodium bicarbonate, quantity: 84 mg/ml - injection, solution - excipient ingredients: disodium edetate; water for injections - sodium bicarbonate injection is indicated as an alkalinising agent in the treatment of metabolic acidosis which may occur in many conditions including diabetes, starvation, hepatitis, cardiac arrest, shock, severe dehydration, renal insufficiency, severe diarrhoea, addison's disease or administration of acidifying salts (e.g. excessive sodium chloride, calcium chloride, ammonium chloride). sodium bicarbonate injection is also used to increase urinary ph in order to increase the solubility of certain weak acids (e.g. cystine, sulphonamides, uric acid) and in the treatment of certain intoxications (e.g. methanol, phenobarbitone, salicylates, lithium) to decrease renal absorption of the drug or to correct acidosis.

Pfizer (Australia) SODIUM BICARBONATE 8.4% (8.4 g/100 mL) injection BP vial Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer (australia) sodium bicarbonate 8.4% (8.4 g/100 ml) injection bp vial

pfizer australia pty ltd - sodium bicarbonate, quantity: 8.4 g - injection, intravenous infusion - excipient ingredients: disodium edetate; water for injections - 1. metabolic acidosis in severe renal disease, uncontrolled diabetes, circulatory insufficiency due to shock or severe dehydration, extracorporeal circulation of blood, cardiac arrest and severe primary lactic acidosis where a rapid increase in plasma total co2 content is crucial. treatment of metabolic acidosis should be concurrent with measures designed to control the cause of the acidosis. 2.urinary alkalinisation in the treatment of certain drug intoxications (ie barbiturates, salicylates, lithium, methyl alcohol) and in the haemolytic reactions requiring alkalinisation of the urine to diminish nephrotoxicity of blood pigments. urinary alkalinisation is also used in methotrexate therapy to prevent nephrotoxicity. 3.severe diarrhoea which is often accompanied by a significant loss of bicarbonate.

Sodium Bicarbonate Injection (AFT) New Zealand - English - Medsafe (Medicines Safety Authority)

sodium bicarbonate injection (aft)

aft pharmaceuticals ltd - sodium bicarbonate 8.4%;  ;   - solution for injection - 8.4 % - active: sodium bicarbonate 8.4%     excipient: disodium edetate sodium hydroxide - sodium bicarbonate is used as an alkalinising agent in the treatment of metabolic acidosis which may occur in many conditions including diabetes, starvation, hepatitis, cardiac arrest, shock, severe dehydration, renal insufficiency, severe diarrhoea, addison's disease or administration of acidifying salts (e.g. excessive sodium chloride, calcium chloride, ammonium chloride). sodium bicarbonate is also used to increase urinary ph in order to increase the solubility of certain weak acids (e.g. cystine, sulphonamides, uric acid) and in the treatment of certain intoxications (e.g. methanol, phenobarbitone, salicylates) to decrease renal absorption of the drug or to correct acidosis.

8.4% w/v Sodium Bicarbonate Intravenous Infusion BP Ireland - English - HPRA (Health Products Regulatory Authority)

8.4% w/v sodium bicarbonate intravenous infusion bp

b. braun medical limited - sodium bicarbonate - solution for infusion - 8.4 percent weight/volume - electrolyte solutions; sodium bicarbonate

Sodium Bicarbonate Injection BP Minijet 8.4% w/v, Solution for Injection Ireland - English - HPRA (Health Products Regulatory Authority)

sodium bicarbonate injection bp minijet 8.4% w/v, solution for injection

international medication systems (uk) ltd - sodium bicarbonate - solution for injection - 8.4 percent weight/volume - electrolyte solutions; sodium bicarbonate

SODIUM BICARBONATE solution United States - English - NLM (National Library of Medicine)

sodium bicarbonate solution

onpharma, inc. - sodium bicarbonate (unii: 8mdf5v39qo) (bicarbonate ion - unii:hn1zra3q20) - sodium bicarbonate 84 mg in 1 ml - sodium bicarbonate inj., 8.4% usp neutralizing additive solution is indicated to hasten onset of analgesia and reduce injection pain, by adjusting commercial preparations of lidocaine w/ epinephrine anesthetic solution to a more physiologic ph. not for use as a systemic alkalizer. barash pg, cullen bf, stoelting rk, clinical anesthesia (4th ed. 2001 lippincott williams and wilken). bhatt h, powell kj, jean da, first aid for the anesthesiology boards, an insider's guide (2011, mcgraw-hill medical). cepeda ms, tzortzopoulou a, thackrey m, hudcova j, arora gandhi p, schumann r., adjusting the ph of lidocaine for reducing pain on injection. cochrane database of systematic reviews 2010, issue 12. art. no.: cd006581. chu lf, clinical anesthesiology board review(2005, mcgraw-hill medical). malamed sf,handbook of local anesthesiology(5th ed. 2004, elsevier mosby). miller rd, miller's anesthesia (6th ed. 2004). stoelting rk, miller rd,basics of anesthesia(5th ed. 2007, churchill livingstone el

SODIUM BICARBONATE- sodium bicarbonate injection United States - English - NLM (National Library of Medicine)

sodium bicarbonate- sodium bicarbonate injection

international medication systems, limited - sodium bicarbonate (unii: 8mdf5v39qo) (bicarbonate ion - unii:hn1zra3q20) - sodium bicarbonate 84 mg in 1 ml - sodium bicarbonate injection, usp is indicated in the treatment of metabolic acidosis which may occur in severe renal disease, uncontrolled diabetes, circulatory insufficiency due to shock or severe dehydration, extracorporeal circulation of blood, cardiac arrest and severe primary lactic acidosis. sodium bicarbonate is further indicated in the treatment of certain drug intoxications, including barbiturates (where dissociation of the barbiturate-protein complex is desired), in poisoning by salicylates or methyl alcohol and in hemolytic reactions requiring alkalinization of the urine to diminish nephrotoxicity of hemoglobin and its breakdown products. sodium bicarbonate also is indicated in severe diarrhea which is often accompanied by a significant loss of bicarbonate. treatment of metabolic acidosis should, if possible, be superimposed on measures designed to control the basic cause of the acidosis – e.g., insulin in uncomplicated diabetes, blood volume restoration in shock. but since an appreciable time int